Broadstreet at ISPOR 2022

Broadstreet is pleased to be presenting several virtual posters at this year’s ISPOR meeting. VISUALIZING NETWORK META-ANALYSES IS NOT TRIVIAL – A NOVEL TAKE ON THE NETWORK DIAGRAM Popoff, E;1…

Continue Reading Broadstreet at ISPOR 2022

In a pandemic, seeing is believing

As life finally (hopefully!) begins to return to normal, over two years since the beginning of the pandemic, now seems like a good moment to reflect a bit on the…

Continue Reading In a pandemic, seeing is believing

A year in review: 2021 at Broadstreet

With 2021 having drawn to a close, we thought we would take the opportunity to look back on what has been another successful year for Broadstreet. Of course, the pandemic…

Continue Reading A year in review: 2021 at Broadstreet

Happy holidays from Broadstreet

As another busy and productive year draws to a close here at Broadstreet, we wanted to take a few minutes to wish our friends, clients and colleagues a safe and…

Continue Reading Happy holidays from Broadstreet

New research from Broadstreet and colleagues on how disease-free survival as a measure of treatment outcome is viewed by cancer survivors

Early clinical successes are becoming more common in oncology; and as a result, there is a need for endpoints that can meaningfully describe outcomes among treated patients. In cases where…

Continue Reading New research from Broadstreet and colleagues on how disease-free survival as a measure of treatment outcome is viewed by cancer survivors

Broadstreet at virtual ISPOR Europe 2021

Broadstreet is pleased to be presenting several posters at this year’s virtual ISPOR Europe meeting. USE OF REAL-WORLD EVIDENCE TO EVALUATE INFLIXIMAB BIOSIMILARS: A SCOPING REVIEW Antoinette Cheung,1 Lauren Powell,1…

Continue Reading Broadstreet at virtual ISPOR Europe 2021